PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data

BACKGROUND: Limited US clinical data are available on the use of aesthetic products in patients with skin of color (SOC). OBJECTIVE: To compare the efficacy and safety of prabotulinumtoxinA for the treatment of glabellar lines in patients with and without SOC. METHODS AND MATERIALS: Post hoc analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Susan C., Grimes, Pearl E., Joseph, John H., Jonker, Anneke, Avelar, Rui L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055193/
https://www.ncbi.nlm.nih.gov/pubmed/33165078
http://dx.doi.org/10.1097/DSS.0000000000002864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055193/
https://www.ncbi.nlm.nih.gov/pubmed/33165078
http://dx.doi.org/10.1097/DSS.0000000000002864

Ejemplares similares